Clinical phytotherapy: Opportunities and problematics;Fitoterapia clinica: Opportunità e problematiche

Annali dell'Istituto Superiore di Sanita

Volumn 41, Issue 1, 2005, Pages 27-33

  Firenzuoli, Fabio ^a,c   Gori, Luigi ^a   Neri, Daniele ^b  

^a Centro di Medicina Naturale   (Italy)

^b SAN GIUSEPPE HOSPITAL   (Italy)

^c Azienda USL 11   (Italy)

Author keywords

Clinical phytotherapy; Medicinal plants; Traditional medicine

Indexed keywords

HERBACEOUS AGENT; PLANT MEDICINAL PRODUCT;

ADVERSE DRUG REACTION; CLINICAL RESEARCH; CONFERENCE PAPER; DRUG INTERACTION; DRUG MECHANISM; DRUG PURIFICATION; DRUG SYNTHESIS; MAGIC; MEDICINAL PLANT; PHYTOTHERAPY; RELIGION; STANDARDIZATION; TRADITIONAL MEDICINE; TREATMENT CONTRAINDICATION; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; HERBAL MEDICINE; HUMAN; ITALY; LEGAL ASPECT; REVIEW; STANDARD; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG INFORMATION SERVICES; EVIDENCE-BASED MEDICINE; HUMANS; ITALY; MEDICINE, HERBAL; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL; WORLD HEALTH ORGANIZATION;

EID: 24344449692     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Firenzuoli F. Fitoterapia. Milano: Masson; 2002.
2. Gensini GF, Conti AA. Le terapie "alternative". Salute e Territorio 2002;luglio-agosto:245-9.
3. Firenzuoli F, Gori L. Fitoterapia basata sull'evidenza. Recenti Prog Med 1999;90(11):628.
4. Menniti-Ippolito F, Gargiulo L, Bologna E, Forcella E, Raschetti R. Use of unconventional medicine in Italy: a national-wide survey. Eur J Clin Pharmacol 2002;58(1):61-4.
5. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomised trials. Am J Med 2000; 108:276-81.
6. Ernst E, Pittler MH. Ginkgo biloba for dementia: a systematic review of double-blind placebo-controlled trials. Clin Drug Invest 1999;17:301-8.
7. Linde K, Mulrow CD. St John's wort for depression. Cochrane Database Syst Rev 2002;Issue 2(a).
8. Stevenson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 2000;133(6):420-9.
9. Block KI, Mead MN. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2003;2(3):247-67.
10. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaaanalysis. Am J Gastroenterol 1998;93(7):1131-5
11. Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause 2004;11(3):246-54.
12. MacKay D. Hemorrhoids and varicose veins: a review of treatment options. Altern Med Rev 2001;6(2):126-40.
13. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001;20;322(7279):134-7.
14. Riley AJ. Yohimbine in the treatment of erectile disorder. Br J Clin Pract 1994;48(3):133-6.
15. Boyle P, Robertson C, Lowe F, Roehrborn. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int 2004;93(6):751-6.
16. Lim TS, Na K, Choi EM, Chung JY, Hwang JK. Immunomodulating activities of polysaccharides isolated from Panax ginseng. J Med Food 2004;7(1):1-6.
17. Ernst E, Pittler MH The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr 2000;3(4A):509-14.
18. Vishwakarma SL, Pal SC, Kasture VS, Kasture SB. Anxiolytic and antiemetic activity of Zingiber officinale. Phytother Res 2002;16(7):621-6.
19. Hallam KT, Olver JS, McGrath C, Norman TR. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers. Hum Psychopharmacol 2003;18(8):619-25.
20. Carai MA, Agabio R, Bombardelli E, Bourov I, Gessa GL, Lobina C, Morazzoni P, Pani M, Reali R, Vacca G, Colombo G. Potential use of medicinal plants in the treatment of alcoholism. Fitoterapia 2000;71(Suppl. 1):S38-42.
21. Serra S, Vacca G, Tumatis S, Carrucciu A, Morazzoni P, Bombardelli E, Colombo G, Gessa GL, Carai MA. Anti-relapse properties of IDN 5082, a standardized extract of Salvia miltiorrhiza, in alcohol-preferring rats. J Ethnopharmacol 2003; 88(2-3):249-52.
22. Calapai G, Crupi A, Firenzuoli F, Costantino G, Inferrera G, Campo GM, Caputi AP. Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J Pharm Pharmacol 1999;51(6):723-8
23. Catania MA, Firenzuoli F, Crupi A, Mannucci C, Caputi AP, Calapai G. Hypericum perforatum attenuates nicotine withdrawal signs in mice. Psychopharmacology 2003;169(2):186-9.
24. Calapai G, Crupi A, Firenzuoli F, Marciano MC, Squadrito F, Inferrera G, Parisi A, Rizzo A, Crisafulli C, Fiore A, Caputi AP. Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 2000;67(22):2673-83.
25. Firenzuoli F, Gori L, Crupi A. Flavonoidi: rischi e opportunità terapeutiche. Recenti Prog Med 2004;94:345-351.
26. Larimore WL, O'Mathuna DP. Herbal products should be regulated for quality control. Am Fam Physician 2004;69(3):493-4.
27. Firenzuoli F. I rischi delle erbe medicinali. In: Proceedings of International Conference Safety Evaluation of Complementary and Alternative Medicine. Empoli, 24-25 ottobre, 2003. p. 7-10.
28. Firenzuoli F, Gori L. Guggulipid and cholesterol levels. JAMA 2003;290(21)2800.
29. Firenzuoli F, Gori L. Echinacea for treating colds in children. JAMA 2004;291:1323-4.
30. Bianchi A, Cantù P, Firenzuoli F, Mazzanti G, Menniti-Ippolito F, Raschetti R. Rhabdomyolysis caused by Commiphora mukul, Natural lipid-lowering agent. Ann Pharmacother 2004;3(7-8):1222-5.
31. Calapai G, Firenzuoli F, Saitta A et al. Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report. Fitoterapia 1999;70(6):586-92.
32. Morini S, Bartoli P, Gori L, Firenzuoli F. Analisi gascromatografica qualitativa e quantitativa del contenuto di efedrina in preparazioni tradizionali di Ephedra sinensis. In: Proceedings of International Conference Safety Evaluation of Complementary and Alternative Medicine. Empoli, 24-25 ottobre, 2003. p. 74-77.
33. Firenzuoli F, Gori L. Rabdomiolisi da liquirizia. Rec Prog Med 2002;93(9):482-3.
34. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 8;355(9198):134-8.
35. Firenzuoli F. Interazioni tra erbe, alimenti e farmaci. Milano: Tecniche Nuove Ed.; 2001.
36. Stevinson C, Ernst E. Safety of hypericum in patients with depression. CNS Drugs 1999;11:125-32.
37. Firenzuoli F, Gori L, Corti G, Manetti M. Interferenza dei fitoestrogeni con il tamoxifene citrato nel trattamento del cancro mammario. Gazz Med Ital 2003;162(4)97-100.
38. De Smet PAGM. Herbal remedies. N Engl J Med 2002;347: 2046-56.
39. Menniti-Ippolito F, Raschetti R, Firenzuoli F, Mazzanti G, Bianchi A. Sorveglianza delle reazioni avverse a prodotti a base di piante officinali. Boll Inf Farmaci 2003;5-6:199-203.
40. Corns CM. Herbal remedies and clinical biochemistry. Ann Clin Biochem 2003;40:489-507.
41. Gensini GF. Fitoterapia e formazione del medico. Toscana Medica 2000;3:8-16.
42. Firenzuoli F. Fitoterapia: perchè non prevedere una specializzazione? La Professione 2003;5(7/8):13.